All publications

Rudolph F, Ramsay KJ, Ramsay MAE, Hein HAT, Carnes K, Turner K. "Accelerators in [Thrombelastograph® Analysis]: Effects of Tissue Factor and Heparinase on the Thrombelastogram During Liver Transplantation." Anesth Analg. 1998;86;S228.

Frenette L, Cox J, McArdle P, Eckhoff D, Bynon S. "Conjugated Estrogen Reduces Transfusion and Coagulation Factor Requirements in Orthotopic Liver Transplantation." Anesth Analg. 1998;86:1183-6.

Kang YG, Gasior TA. "Blood Coagulation During Liver, Kidney, Pancreas, and Lung Transplantation." Perioperative Transfusion Medicine. 1998.

Kettner SC, Gonano C, Seebach F, Sitzwohl C, Acimovic S, Stark J, Schellongowski A, Blaicher A, Felfernig M, Zimpfer M. "Endogenous Heparin-Like Substances Significantly Impair Coagulation in Patients Undergoing Orthotopic Liver Transplantation." Anesth Analg 1998;86:691-5.

Pivalizza EG, Abramson DC, King FS. "[Thrombelastograph® Analysis] With Heparinase in Orthotopic Liver Transplantation." Journal of Cardiothoracic and Vascular Anesthesia. June 1998:V12,No 3: pp 305-308.

Kaspar M, Ramsey MAE, Nguyen AT, et al. "Continuous Small-Dose Tranexamic Acid Reduces Fibrinolysis but not Transfusion Requirements During Orthotopic Liver Transplantation." Anesth Analg 1997;85:281-5.

Frenette L, et al. "Conjugated Estrogens Decrease Transfusion Requirements of Fresh Frozen Plasma (FFP) and Red Blood Cells (RBC) During Orthotopic Liver Transplantation (OLT)." Fourth Congress of the ILTS. October 15-17, 1997.

Pivalizza EG, Abramson DC, King F. "Heparinase-Celite [Thrombelastograph® Analysis] in Liver Transplantation." Anesthesiology. Sept. 1997. V87, No 3A.

Kaspar M, Cogswell ME, Hurst G, Nguyen AT, Ramsay MAE, Ramsay KJ. "Infusion of Small Dose Tranexamic Acid Reduces Fibrinolysis During Orthotopic Liver Transplantation." Anesth Analg. 1997;84;S163.

Harding SA, Mallett SV, Peachey D, Cox DJ. "Use of Heparinase Modified [Thrombelastograph® Analysis] in Liver Transplantation." British Journal of Anaesthesia. 1997;78;175-179.

Turner K, Carnes K, Kaspar M, Meng J, Ramsay MAE, Marcel RJ, Hein HAT. "Accelerated [Thrombelastograph® Analysis] in Orthotopic Liver Transplantation." Anesthesiology. Sept. 1997:V87:No3A.

Gonano C, Kettner S, Bohm D, et al. "Detection of Heparin Effects with Heparinase Modified [Thrombelastograph® Analysis] (TEG[®]) in Liver Transplantation (OLT) without Veno-Venous Bypass." Anesthesiology. Sept. 1996;V85, No. 3A.

Pivalizza EG. "Heparinase and [Thrombelastograph® Analysis] in Liver Transplantation for a Patient with von Willebrand's Disease." Anesthesiology. May 1996, V84, No. 5.

Kang Y. "[Thrombelastograph® Analysis] in Liver Transplantation." Seminars in Thrombosis and Hemostasis. 1995. V21 Supplement 4.

Gillies BSA. "[Thrombelastograph® Analysis] and Liver Transplantation." Seminars in Thrombosis and Hemostasis. 1995. V21 Supplement 4.

Green MA, Plevak DJ, Schroeder DR, Offord KP, Rettke SR, Bowie EJW. "Celite [Thrombelastograph® Analysis] & Fibrinogen as Predictors of Hemorrhage During Liver Transplantation." Joint Congress on Liver Transplantation. September 1995, p25.

Kettner S, Seebach F, Felfernig M, Blaicher A, Zimpfer M. "Heparinase Modified [Thrombelastograph® Analysis] (TEG[®]) in Orthotopic Liver Transplantation (OLT) Without Veno-Venous Bypass (VVB)." Joint Congress on Liver Transplantation. September 1995, p28.

Pannell MA, Milroy SJ, McGinty M, Oyesola BO, Cottam SC, Potter D. "The Straight Line Reperfusion [Thrombelastograph®] (TEG[®]) Trace: Heparin or Fibrinolysis?" Joint Congress on Liver Transplantation. September 1995, p36.

Woo S, Nho JS, Lee BJ, Kim MC, Cho KH. "Heparinase Is More Reliable Than Protamine for Detecting Heparin Effect on [Thrombelastograph® Analysis] on Reperfusion of Liver Transplantation." Joint Congress on Liver Transplantation. September 1995, p52.

Clayton DG, Miro AM, Kramer DJ, et al. "Quantification of [Thrombelastograph®] Changes After Blood Component Transfusion in Patients with Liver Disease in the Intensive Care Unit." Anesth Analg. August 1995, V81 pp272-278.

McNicol PL, Liu G, Harley ID, McCall PR, et al. "Patterns of Coagulopathy During Liver Transplantation: Experience with the First 75 Cases Using [Thrombelastograph® Analysis]." Anaesthesia and Intensive Care. December, 1994. V22., No. 6.

Ramos HC, Todo S, Kang Y, Felekouras E, Doyle HR, Starzl TE. "Liver Transplantation Without the Use of Blood Products." Arch Surg. 1994;129:528-533.

Cox DJA, Mallett SV. "Post reperfusion coagulopathy is reversed by Heparinase." International Liver Transplantation Society. October 6-8, 1993. P32.

Freys G, Pain L, Calon B, et al. "Early Predictors of Transplanted Liver Function." Anesthesiology. Sept. 1993. V79, No. 3A.

Frenette L, Doblar DD, Boyd GL, et al. "In Vitro Study of the Effects of Conjugated Estrogens on Coagulation During Orthotopic Liver Transplantation (OLT)." Anesthesiology. Sept. 1993. V79, No. 3A.

Csete M, Mason T, Neelakanta G, et al. "Desmopressin Acetate (DDAVP) is not Effective in Treating Coagulopathy During Liver Transplantation." Anesthesiology. Sept. 1993. V79, No. 3A.

Dishart M, DeWolf A, Gasior T, et al. "Right Ventricular Response to a Volume Challenge During Orthotopic Liver Transplantation." Anesthesiology. Sept. 1993. V79, No. 3A.

Clayton DG, Miro AM, Kramer DJ, et al. "Quantification of [Thrombelastograph®] Changes After Blood Component Transfusion in Patients with Liver Disease." Anesthesiology. Sept. 1993. V79, No. 3A.

Plevak DJ, Divertie GD, Carton E, Bowie EJ, Rettke SR, Taswell HF, Wiesner RH. "Blood Product Transfusion Therapy after Liver Transplantation(LT): Comparison of the [Thrombelastogram®] (TEG[®]) and Conventional Coagulation Studies (CCS)." Congress of the International Liver Transplantation Society. April 29-May 2, 1992. p72.

Spiess BD, "Anesthesia." Hepatic Transplantation. Ed. Williams JW. 1990. pp183-206.

Kang YG, Boraland L, Picone J, Martin L. "Intraoperative Coagulation Changes in Children Undergoing Liver Transplantation." Anesthesiology. 1989;71:44-47.

Kang YG, "Monitoring and Treatment of Coagulation." Hepatic Transplantation. 1986. 151-173.

Kang YG, Martin DJ, Marquez J, et al. "Intraoperative Changes in Blood Coagulation and [Thrombelastograph®] Monitoring in Liver Transplantation." Anesthesia and Analgesia. 1985. 64(9):888-896.

Cardiac Surgery

Robbins P, Von Kier S, Forrest M, Royston D. "Activated Clotting Times are Shortened by Tranexamic Acid." Anesthesiology. Sept. 1998, V89, No 3A, A962.

Von Kier S, Royston D. "Reduced Hemostatic Factor Transfusion using Heparinase-Modified [Thrombelastograph® Analysis] (TEG[®]) During Cardiopulmonary Bypass (CPB)." Anesthesiology. Sept. 1998, V89, No. 3A, A911.

Shore-Lesserson L, Manspeizer HE, Francis S, DePerio M. "[Thrombelastograph® Analysis] Decreases Transfusion Requirements after Cardiac Surgery." Anesthesiology. Sept. 1998, V89, No3A, A246.

Stammers AH, Bruda NL, Gonano C, Hartmann T. "Point-of-care coagulation monitoring: applications of the [Thrombelastograph®]." Anesthesia. 1998,53 (Suppl 2), pp 1-80.

Spiess BD. "Perioperative Coagulation Monitoring." Perioperative Transfusion Medicine. 1998.

Kettner SC, Kozek SA, Groetzner JP, Gonano C, Schellongowski A, Kucera M, ZimpferM. "Effects of hypothermia on [Thrombelastograph® Analysis] in patients undergoing cardiopulmonary bypass." British Journal of Anaesthesia. 1998;80:313-317.

Ereth MH, Nuttall GA, Santrach PJ, Klindworth JT, Oliver WC, Schaff HV. "The Relation between the Platelet-activated Clotting Test (HemoSTATUS) and Blood Loss after Cardiopulmonary Bypass." Anesthesiology. 1998;88:962-9.

Shore-Lesserson L, Manspeizer HE, Francis S, DePerio M. "Intraoperative [Thrombelastograph® Analysis] (TEG[®]) Reduces Transfusion Requirements." Anesth Analg. 1998;86;SCA101.

Shore-Lesserson L, Manspeizer HE, Francis S, DePerio M. "Heparinase-Modified [Thrombelastograph® Analysis] During Bypass Predicts Mediastinal Tube Drainage." Anesth Analg. 1998;86;S104.

Takeda T, Kohro S, Yamakage M, et al. "Effect of Recycled Autologous Blood Transfusion on in Vitro Blood Coagulability and Fibrinolysis." Anesth Analg. 1998:86;S110.

Shulman G, McQuitty C, Vertrees RA, Conti VR. "Acute Normovolemic Red Cell Exchange for Cardiopulmonary Bypass in Sickle Cell Disease." Ann Thorac Surg. 1998;65.

Ficek SJ, Stammers A, Ubeydullah D, et al. "Hemostatic Assessment of Patients Undergoing Intraaortic Balloon Pump Therapy." Journal of Extra-Corporeal Technology. June 1997. V29, No 2.

McCarthy RJ, Tuman KJ, El-Ganzouri N, Ivankovich AD. "Influence of Heparin Reversal Methods on Whole Blood [Thrombelastograph®] Measures of Coagulation." Anesth Analg. 1997;84;S104.

O'Connor CJ, Tuman KJ, McCarthy RJ, McCarthy WE, Ivankovich AD. "Multivariate Predictors of Bleeding and Transfusion in Reoperative CABG Surgery." Anesth Analg. 1997;84;S114.

Wolman RL, Bardwell PS, Embrey J, Bowman T, Michael J, O'Rourke P, Roberts J, Weiss J, Shapiro J. "Empirical Versus TEG[®]-Guided Transfusion Practices During Cardiac Surgery." Anesth Analg. 1997;84;S223.

Tomiyama Y, Yasumoto S, Sakata S, Kitahata H, Kimura H, Oshita S. "Coagulation Status of the Whole Blood Preoperatively Obtained in the Operating Room and Preserved at Room Temperature [Thrombelastograph®] Evaluation." Anesthesiology. September 1996. V85. No. 3A.

Spiess BD. "Coagulation Monitoring in the perioperative period." Acta Anaestheisologica Scandinavica. 1996;109;V40:M29.

Soltow LO, Spiess BD, Wahr J, Herskowitz A, et al. "Does Acadesine Contribute to Hypocoagulability after CABG Surgery." Anesth Analg. 1996;82,SCA97.

Zimmermann J, McIntosh C, Clementi W, et al. "Heparin Reversal with NeutralaseTM (HEPARINASE I) in Adult Male Volunteers. Anesth Analg. 1996;82,SCA93.

Robbins P, Forrest M, von Kier S, Royston D. "Can the [Thrombelastograph®] (TEG[®]) Predict Dose Requirement for Aprotinin Therapy?" Anesthesiology. Sept. 1996. V85, No. 3A.

Spiess BD. "[Thrombelastograph® Analysis] and Cardiopulmonary Bypass." Seminars in Thrombosis and Hemostasis. 1995. V21 Supplement 4.

Shore-Lesserson L, Reich DL, DePerio M, Silvay G. "Autologous Platelet-Rich Plasmapheresis: Risk Versus Benefit in Repeat Cardiac Operations." Anesth Analg. 1998;81:229-35.

Spiess BD, Gilles B, Chandler W, Verrier E. "Changes in Transfusion Therapy and Reexploration Rate After Institution of a Blood Management Program in Cardiac Surgical Patients." Journal of Cardiothoracic and Vascular Anesthesia. April 1995: V9, No.2. pp168-173.

Thwaites BK, Mongan PD, Brown RS. [Thrombelastograph®] Evidence of Fibrinolysis Strongly Predicts Excess Bleeding After Cardiopulmonary Bypass." Anesthesia & Analgesia. April 1995;V80, No. 4S.

Etzioni DA, Tobias MD, Jobes DR. "[Thrombelastograph® Analysis] Results are Easily Affected by Sample and Technique." Anesthesia & Analgesia. April 1995. V80, No. 4S.

Copeland JG, Tsau PH, Arabia FA, Xie T. "Correlation of Clinical Embolic Events with Coagulability in a Patient with a Total Artificial Heart." Journal of Heart and Lung Transplantation. 1995; V14, No. 5.

McCarthy RJ, Tuman KJ, Holm WE, Ivankovich AD. "Effects of Aspirin on Homologous Blood Requirements after Repeat Cardiac Operations." Anesthesia & Analgesia. Feb. 1995; V80, No. 2S.

McCarthy RJ, Tuman KJ, Bednar LA, Holm WE, Ivankovich AD. "Effects of Heparinase and Protamine on Whole Blood Coagulation in the Presence and Absence of Heparin." Anesthesiology. September 1994;81(3A).

Spiess BD, Soltow LO. "[Thrombelastograph® Analysis] is Best Preserved in High Dose Aprotinin Treated Repeat CABG Patients." Anesthesiology. September 1994;81(3A).

Spiess BD, Soltow L, Dobbyn R, Chandler WL. "The Effects of Cardiopulmonary Bypass on Shear Moduleus in a Clinical Series of Cardiopulmonary Bypass Patients as Measured by [Thrombelastograph® Analysis] ." Anesthesiology. September 1994;81(3A).

MaGuire DP, McNulty SE. "Heparin Bonded Pulmonary Artery Catheters May Affect the Thromboelastogram and Activated Coagulation Time." Anesthesiology. September 1994;81(3A).

Spiess BD, Soltow L, Dobbyn R. "[Thrombelastograph® Analysis] Preoperatively can Predict Postoperative Risk of Severe Hemorrhage in Valve Surgery: A Report of a Clinical Series." Anesthesiology. September 1994; 81(3A).

Tuman KJ, McCarthy R, Djuric M, Rizzo BA, Ivankovich A. "Evaluation of Coagulation During Cardiopulmonary Bypass with a Heparinase-Modified [Thrombelastograph®] Assay." Journal of Cardiothoracic and Vascular Anesthesia. (April), 1994:V8, No.2, pp144-149.

McCarthy R, Tuman K, Ivankovich AD. "Heparinase Enhanced Whole Blood [Thrombelastograph® Analysis] During Cardiopulmonary Bypass is Predictive of Coagulation Status after Protamine Reversal of Heparin." Anesthesiology. Sept. 1993, V79, No. 3A.

McCarthy R, Tuman K, Djurie M, Rizzo V, Ivankovich AD. "Effect of Heparinase on Viscoelastic Coagulation Measurements in the Presence and Absence of Heparin." Anesthesiology. Sept. 1993, V79, No. 3A.

Wall MH, Spiess BD, Gillies B, Chandler WL. "[Thrombelastograph® Analysis] With Added Heparinase or Protamine Sulfate During Cardiopulmonary Bypass." Anesthesiology. Sept. 1993, V79, No.3A.

Essels JH, Martin TJ, Salinas J, Thompson JM, Smith VC. "Comparison of [Thrombelastograph® Analysis] to Bleeding Time and Standard Coagulation Tests in Patients After Cardiopulmonary Bypass." Journal of Cardiothoracic and Vascular Anesthesia. August 1993, V7, No. 4, pp410-415.

Dorman BH, Spinale FG, Bailey MK, Kratz JM, Roy RC. "Identification of patients at risk for excessive blood loss during coronary artery bypass surgery: [Thrombelastograph® Analysis] versus coagulation screen." Anesth Analg April 1993; V76;694-700.

McCarthy R, Tuman K, Djuric M, Rizzo V, Ivankovich AD. "Use of Heparinase to Evaluate Coagulation During Cardiopulmonary Bypass with Systemic Heparinization." Anesthesiology. September 1992;77(3A).

Mongan P, Hosking M. "The Role of Desmopressin Acetate in Patients Undergoing Coronary Artery Bypass Surgery." Anesthesiology. 1992:77:38-46.

Baeuerle JJ, Mongan PD, Hosking MP. "An Assessment of the Duration of Cephapirin-Induced Coagulation Abnormalities as Measured by the [Thrombelastograph®]." Anesthesiology. 1991:75(3A).

Wong CA, Jones JH, Wade L. "Comparison of Act and TEG[®] in Patients Receiving Autologous Platelet-Rich-Plasma during Cardiac Surgery." Anesthesiology. 1991:75(3A).

Lake, CB, ed. "Intraoperative Evaluation of Haemostasis." Clinical Monitoring. Philadelphia: WB Saunders, 1990 pp 558-574.

Spiess, BD. "Coagulation Function in Operating Room." The Hemorrhagic Disorders, Anesthesia Clinics of North America. WB Saunders. 1990:13:481-499.

Weiss J, McNulty S, Schmitz T. "[Thrombelastograph®] Evaluation of the Effect of Cell Saver Blood on Coagulation in the Post Cardiopulmonary Bypass Patient." Anesthesiology. 1990:72(3A).

Spiess BD, Ivankovich AD. "[Thrombelastograph® Analysis]: A Coagulation-Monitoring Technique applied to Cardiopulmonary Bypass." Monograph of the Society of Cardiovascular Anesthesia. Ed. Ellison and Jobes: 1988.

Spiess B, Tuman K, McCarthy R, DeLaria A, Schillo R, Ivankovich AD. "[Thrombelastograph® Analysis] as an Indicator of Post-Cardiopulmonary Bypass Coagulopathies." Journal of Clinical Monitoring. 1987:3:25-30.

Tuman KJ, Spiess B, McCarthy R, Ivankovich AD. "Effects of Progressive Blood Loss on Coagulation as Measured by [Thrombelastograph® Analysis]." Anesth Analog. 1987:66:856-63.

Tuman K, Spiess B, Schoen R, Ivankovich AD. " Use of [Thrombelastograph® Analysis] in the Management of von Willebrand's Disease During Cardiopulmonary Bypass." Journal of Cardiothoracic Anesthesia. 1987:1(4):321-324.

 Urban MK, Beckman J, et al. "Anti-fibrinolytics reduce blood loss during complex spine surgery." Anesthesiology. Sept. 1997:V87, No 3A.

Brown RS, Thwaites BK, Mongan PD. "Tranexamic Acid is Effective in Decreasing Postoperative Bleeding and Transfusions in Primary Coronary Artery Bypass Operations: A Double-Blind, Randomized, Placebo-Controlled Trial." Anesth Analg 1997;85:963-70.

Haddy SM, Shelly WW, Rice N. "Intravascular Thrombosis After Exsanguination in a Patient Treated With Epsilon-Aminocaproic Acid." Journal of Cardiothoracic and Vascular Anesthesia. June 1996, 510-512; V10, No. 4.

Bell CRW, Cox DJA, Murdock PJ, Sullivan ME, Pasi KJ, Morgan RJ. "[Thrombelastograph®] Evaluation of Coagulation in Transurethral Prostatectomy." British Journal of Urology. (1996):78,737-741.

Thwaites BK, Mongan PD, Brown RS. "[Thrombelastograph®] Evidence of Fibrinolysis Strongly Predicts Excess Bleeding After Cardiopulmonary Bypass." Anesth Analg. 1995;80;SCA1-SCA141.

Brown RS, Mongan PD, Thwaites BK. "Tranexamic Acid Decreases Fribrinolysis, Bleeding and Blood Transfusions in Primary CABG." Anesthesia & Analgesia. April 1995:V80, No. 4S.

Palmer JD, Francis DA, Roath OS, Francis JL, Iannotti F. "Hyperfibrinolysis during intracranial surgery: effect of high dose aprotinin." Journal of Neurology, Neurosurgery and Psychiatry. 1995:58:104-106.

Kang YG. "Clinical Use of Synthetic Antifibrinolytic Agents during Liver Transplantation." Seminars in Thrombosis and Hemostasis. 1993:19(3):258-261.

Whitten C, et al. "[Thrombelastograph® Analysis] Preferred to D-Dimer Measurement for Determining Fibrinolysis." Anesthesiology News. Feb. 1992.

Whitten CW, Allison PW, Latson TW, Elmore J, Gulden RH, Burkhardt D, Hyndman V. "[Thrombelastograph®] Fibrinolysis Does not Correlate with Levels of Dimers after Cardiopulmonary Bypass." Anesthesiology. 1991:75(3A).

Kang YG, Lewis JH, Navalgund A, Russell MW, Bontempo FA, Niren LS, Starzl TE. "Epsilon-aminocaproic Acid for Treatment of Fibrinolysis During Liver Transplantation." Anesthesiology. 1987:66(6):766-773.

Pan PH, Moore C, Fragneto R, Ross V, DiNunzio G. "Different Epidural Local Anethestics May Affect the Success Rate of Prophylactic Epidural Blood Patch." Anesthesiology. Presented at the Obstetrics Anesthesia and Perinatology 30th Annual Meeting. April 1998.

Gershon RY, Dolak J, Board E, Stack K, Silva V, Hartke D, Azran M. "Platelets and the HIV-Infected Parturient." Anesth Analg. 1998:86:S368.

Sharma SK, Philip J, Landers DF. "The use of whole blood activators in [TEG®] Measurements reduces intersample variability and increases reliability." Anesth Analg. 1998;86;S386.

Sharma SK, Philip J, Wiley J, Cross S. "Activated [Thrombelastograph® Analysis]: Assessment of Coagulation Abnormalities in Preeclamptic Patients." Anesth Analg. 1998;86;S387.

Campos CJ, Pivalizza EG, Abouleish EI. "[Thrombelastograph® Analysis] in a Parturient with Immune Thrombocytopenic Purpura." Anesth Analg 1998;86:675-81.

Gershon RY, Dolak J, Stack K, Board E, Silva V. "The Cocaine-Abusing Parturient Is Not at an Increased Risk for Thrombocytopathy." Anesthesiology Sept. 1997:V87, No 3A.

Sharma S, Phillip J, Cross S, Hayes B, Wiley J. "Crystalloid administration prior to spinal anesthesia does not affect blood coagulability in parturients as measured by [Thrombelastograph® Analysis]." Anesthesiology. Sept. 1997:V87, No 3A.

Sharma SK, Philip J, Perez B, Wiley J. "[Thrombelastograph® Analysis] Using Tissue Factor and Celite: Normal Measurements in Pregnant and Postpartum Women." Anesthesiology. Sept. 1996:V85, No. 3A.

Orlikowski CEP, Rocke DA, Murray WB, Moodley J, Byrne S, Kenoyer DG, Byrne S. "[Thrombelastograph® Analysis] Changes in Pre-eclampsia and Eclampsia." British Journal of Anaesthesia. 1996:V77: 157-161.

Lowenwirt I, Dadic P, Krishnamurthy V. "Essential Thrombocythemia and Epidural Analgesia in the Parturient." Regional Anesthesia 1996:21(6):525-528.

Sharma S, et al. Assessment of Coagulation of Parturients With [Thrombelastograph® Analysis] During Massive Blood Loss. 27th Annual Meeting Society for Obstetric Anesthesia and Perinatology. May 17-20, 1995.

Sharma S, Wallace D, Sidawi E, Whitten C, Davenport M, Gambling D. "[Thrombelastograph® Analysis]: Assessment of Coagulation Abnormalities in Preeclamptic Patients." Anethesia & Analgesia. Feb. 1995, V80, No. 2S.

Sharma S, Wallace D, Sidawi E, Lacour T, Yamanouchi K, Padaklandla. [Thrombelastograph® Analysis] with Disposables Cups & Pins: Normal Measurements in Non-Pregnant, Pregnant, and Post-Partum Women." Anesthesia & Analgesia. Feb. 1995:V80, No. 2S.

Joseph A, Turnage WS, Saviello GM. "Native and Celite Activated Thrombelastogram in Parturients." Anesthesia & Analgesia. Feb. 1995:V80, No. 2S.

Whitta RKS, Cox DJA, Mallett SV. "[Thrombelastograph® Analysis] reveals two causes of haemorrhage in HELLP syndrome." British Journal of Anaesthesia. 1995:74:464-468.

Orlikowski CEP, Rocke DA. "Coagulation Monitoring in the Obstetric Patient." International Anesthesiology Clinics. Spring 1994, V 32, No.2, pp 173-191.

Chadwick HS, Wall MH, Chandler W, Ross BK. "[Thrombelastograph® Analysis] in Mild and Severe Preeclampsia." Anesthesiology. Sept. 1993:79(3A).

Orlikowski CEP, Rocke DA, Murray WB, Moodley J, Byrne S, Kenoyer DG, Gouws E. "[Thrombelastograph® Analysis] as a Measure of Adequate Hemostasis in Preeclampsia/Eclampsia." Society of Obstetric Anesthesia and Perinatology. May 5-8, 1993, p28.

Wall MH, Chadwick HS, Chandler W, Ross BK. "[Thrombelastograph® Analysis] in Healthy Laboring Women and in Women Receiving Magnesium for Premature Labor." Society of Obstetric Anesthesia and Perinatology. May 5-8, 1993, p29.

Campbell C, Nahrwold M. "Is [Thrombelastograph® Analysis] Useful for Evaluation of Coagulopathies in High-Risk Parturients?" Anesthesiology. 1988:73(3A).

Fisch IR, Freedman SH. "Oral Contraceptives, ABO Blood Groups, and In Vitro Fibrin Formation." Obstetrics and Gynecology. 1975:45(4): 473-479.

 Handa A, Cox DJ, Hamilton G, Pasi KJ, Perry DJ. "[Thrombelastograph® Analysis]: An effective screening test for prothrombotic states." Presented at XVIth Congress of the International Society on Thrombosis and Haemostasis. June 6-12, 1997.

Summaria L. "[Thrombelastograph®] Study of Fibrinolytic Agents." Seminars in Thrombosis and Hemostasis. 1995: Supp 4, V21.

Summaria L, Sandesara J, Yang G, Vagher JP, Caprini JA. "In Vitro Comparison of Fibrinolytic Activity of Plasminogen Activators Using a [Thrombelastograph®] Method: In Vivo Evaluation of the B-Chain-Streptokinase Complex in the Dog Model Using Pre-Titered Doses." Thrombosis and Haemostasis. 1986:56(1):71-79.

Ben-Ari Z, Panagou M, Patch D, et al. "Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by [Thrombelastograph® analysis]." J Hepatol. Mar 1997;26:554-559.

Robbins P, Forrest M, Fanning S, Royston D. "Use of Aprotinin Therapy in a Patient with Factor V Leiden." Anesth Analg 1997;84:694-8.

Hsu HW, Huang CH, Chang Y, Shih RL, Chen LK, Chen TL. "Perioperative alterations of the [Thrombelastograph® analysis] in patients receiving one-stage bilateral total knee arthroplasty." Acta Anaesthesiol Sin. Sept. 1996;34:129-134.

Felfernig M, Schmid E, Seebach F, Gonano C, et al. "Perioperative Coagulation Risks in HIV-Patients." Anesthesiology. Sept. 1996:V85, No. 3A.

Karoutsos S, Nathan N, Benrhaiem M, et al. "[Thrombelastograph®] Changes Induced by Three Plasma Substitutes During Orthopedic Surgery." Anesthesiology. Sept. 1996: V85, No. 3A.

Wolf A, Gologorsky E, Scott V, Aggarwal S, Dishart M, Kang Y. "Intravascular and Intracardiac Thrombus Formation and Pulmonary Thromboembolism Immediately After Graft Reperfusion in Six Patients Undergoing Liver Transplantation." Joint Congress on Liver Transplantation. September 1995, C4.

Arcelus JI, Traverso CI, Caprini JA. "[Thrombelastograph® Analysis] for the Assessment of Hypercoagulability During General Surgery." Seminars in Thrombosis and Hemostasis. 1995:Suppl. 4, V21.

Caprini JA, Arcelus JI, Laubach M, et al. "Postoperative hypercoagulability and deep-vein thrombosis after laparoscopic cholecystectomy." Surgical Endoscopy. (1995) 9: 304-309.

Murray WB, Rocke DA, Hammer A, Wakefield M, Russel H. "The Effect of the Low Molecular Weight Heparin (Enoxaparin) on the Thrombelastogram (TEG[®])." Anesthesiology. September 1994:81(3A).

Gibbs NM, Crawford GPM, Michalopoulos N. "[Thrombelastograph®] Patterns Following Abdominal Aortic Surgery." Anaesth. Intens Care. 1994:22: 534-538.

Traverso C, Arcelus JI, Gomez E, Luna D, Lopez-Cantarero M, Garcia JM. "Prospective assessment of the risk of deep vein thrombosis in elective abdominal surgery. Predictive role of [Thrombelastograph® analysis]." Thromb Haemorrh Disorders. 1993:71:9-15.

Heather BP, Jennings SA, Greenhalgh RM. "The saline dilution test - a preoperative predictor of DVT. Br. J. Surg. 1980;V67:63-65.

Watts DD, Trask A, Soeken K, Perdue P, Dols S, and Kaufmann C, et al. "Hypothermic Coagulopathy in Trauma: Effect of Varying Levels of Hypothermia on Enzyme Speed, Platelet Function, and Fibrinolytic Activity." Journal of Trauma: Injury, Infection and Critical Care. 1998:V44;No.5.

Kettner SC, Kozek SA, Schellongowski A, et al. "Effects of decreased body temperature on [Thrombelastograph® analysis] in patients undergoing cardiopulmonary bypass." Anesthesiology. Sept. 1997:V87, No 3A.

Kettner SC, Sitzwohl CH, Kozek S, Pohl G, Spiss CK, Illievich UM. "Effect of Graded Hypothermia (36oC-32oC) on Whole Blood Coagulation Monitoring, in Patients Without Surgical Trauma." Anesthesiology. Sept. 1996:V85, No. 3A.

Rubin I, Swica H, Belani K, Bhatia S, Sessler D. "Effects of In-vitro Alterations in Temperature on [Thrombelastograph® Analysis] -Implications During Liver Transplantation." Joint Congress on Liver Transplantation. September 1995, C3.

Douning Lk, Ramsay MA, Swygert TH, et al. "Temperature Corrected [Thrombelastograph® Analysis] in Hypothermic Patients." Anesth Analg. Sept. 1995. V81; pp 608-611.

Rubin I, et al. "Effects of In-Vitro Alterations in Temperature on the Thromboelastogram." Anesthesiology. Sept. 1995:V83, No. 3A.

Joy JV, Glosten B, Chandler WR, Spiess BD. "Hyperthermia and Coagulation as Measured by a Temperature Controlled Thromboelastograph." Anesthesia & Analgesia. April 1995: V80, No. 4S.

Douning L, Biering P, Fang X, Arnold J, Ramsay M, Gunning T. "Temperature Effect on Thromboelastograph: A Comparative Study." Anesthesia & Analgesia. Feb. 1995:V80, No. 2S.

Stapelfeldt WH, Bjerke RJ, Labuda M, Kalman J, Edelstein S, Janowitz M, Yland M, Drobycki T. "Effect of Hypothermia on the Thrombelastogram." Anesthesiology. September 1994:81(3A).

McCarthy RJ, Tuman KJ, Chen B, Ivankovich AD. "Platelet Integrin Inhibition with c7E3 Enhances the Correlation between Platelet Aggregometry and [Thrombelastograph®] (TEG[®]) MA Values." Anesth Analg. 1998;86;S219.

Greilich PE, Carr ME, Cooley MV, et al. "Dose Dependent Effects of c7E3 Fab on Modified [Thrombelastograph® Analysis] in Healthy Volunteers." Anesth Analg. 1998;86;S64.

McNulty SE, Sasso P, Vesci J, Schieren H. "Platelet Concentrate Effects on [Thrombelastograph® Analysis]." Journal of Cardiothoracic and Vascular Anesthesia. December 1997:V11, No. 7, pp 828-830.

Heerden PVV, Gibbs NM, Michalopoulos N. "Effect of Low Concentrations of Prostacyclin on Platelet Function in vitro." Anesthesia Intensive Care. 1997; 25: 343-346.

Khurana S, Mattson JC, Westley S, O'Neill WW, Timmis GC, Safian RD. "Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated [Thrombelastograph® analysis]." J Lab Clin Med 1997:V130, No. 4, 401-411.

Greilich PE, Alving BM, O'Neill KL, Chang AS, Reid TJ. "A Modified [Thrombelastograph®] Method for Monitoring c7E3 Fab in Heparinized Patients." Anesth Analg. 1997;84:31-8.

Klindworth JT, MacVeigh I, Ereth MH. "The Platelet Activated Clotting Test (PACT) Predicts Platelet Dysfunction Associated With Cardiopulmonary Bypass (CPB)." Anesth Analg. 1996;82;SCA99.

Patel R, Tuman KJ, Patel RB, McCarthy RJ, Ivankovich AD. "Comparison of [Thrombelastograph® Analysis] and Platelet Aggregometry." Anesthesiology. Sept. 1991:V72, No 3A.

Royston D. "Aprotinin Prevents Bleeding and Has Effects on Platelets and Fibrinolysis." Journal of Cardiothoracic and Vascular Anesthesia. 1991:5(6):18-23.

Gaetano G, Bottecchia D, Vermylen J. "Effect of Platelets on Clot Structuration. A [Thrombelastograph®] Study." Thrombosis Research. 1973:V3, 425-435.

Jamnicki M, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR. "Comprised Blood Coagulation: An In Vitro Comparison of Hydroxyethl Starch 130/0.4 and Hydroxyethyl Starch 200/0.5 Using [Thrombelastograph® Analysis]." Anesth Analg 1998;87:989-93.

Gan TJ, Glass PSA, Robertson K, El-Moalem H, Hilton AB, Kucmeroski D, Dufore S, Mythen MG, and the Hextend study group. "The Effects of Hextend and Hespan on [Thrombelastograph® Analysis]." Anesthesiology. Sept. 1998, V89, No. 3A;A909.

Ruttmann TG, James MFM, Aronson I. "In vivo investigation into the effects of haemodilution with hydrozyethyl starch (200/0.5) and normal saline on coagulation." British Journal of Anaesthesia 1998;80:612-616.

Mortier E, Ongenae M, Baerdemaeker De, Herregods L, Blauwen DN, et al. "In Vitro evaluation of the effect of profound haemodilution with hydroxyethl starch 6%, modified fluid gelatin 4% and dextran 40 10% on coagulation profile measured by [Thrombelastograph® analysis]." Anesthesia. 1997:52: pp. 1061-1064.

Jones SB, Despotis GJ, Whitten CW, Monk TG. "The Effect of Replacement Fluid Choice on Coagulation Variables and Blood Loss in Patients Undergoing Acute Normovolemic Hemodilution." Anesthesiology. Sept. 1997:V87, No 3A.

Welsby IJ, Gan TJ, Cooper A, Mythen M, Glass PSA. "[Thrombelastograph®] Changes Following 6% Hetastarch Administration for the Treatment of Perioperative Hypovolemia." Anesthesiology. Sept. 1997. V87, No3A.

Blaicher AM, Zakel D, Decker G, Blaicher W, Felfernig M, Kettner S, et al. "Effect of Hydroxyethl-starch and Lactated Ringer Solution on [Thrombelastograph® Analysis] in Patients Without Surgical Trauma." Anesthesiology. Sept. 1997. V87, No3A.

Jones SB, Despotis GJ, Whitten CW, Monk TG. "The Effect of Replacement Fluid-Choice on Coagulation Variables and Blood Loss in Patients Undergoing Acute Normovolemic Hemodilution." Anesthesiology. Sept. 1997: V87, No3A.

Egli GA, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR. "Effect of progressive haemodilution with hydroxyethl starch, gelatin and albumin on blood coagulation." British Journal of Anaesthesia. 1997;78: 684-689.

Tobias MD, Wambold D, Galli K, Greer F. "Hemodilutions with Saline, Albumin, and Hetastarch Exert Differential Effects upon Whole Blood Coagulation." Anesthesiology. September 1996:V85, No. 3A.

KFJ NG, JWR LO. "The Development of Hypercoagulability State, as Measured by [Thrombelastograph® Analysis], Associated With Intraoperative Surgical Blood Loss." Anesthesia Intens Care. 1996:V24: 20-25.

Bernstein CA, Waters JH. "[Thrombelastograph®] Change Following Hetastarch or Albumin." Anesth Analg. 1996;82;S26.

Ruttmann TG, James MFM, Viljoen JF. "Haemodilution Induces a Hypercoagulable State." British Journal of Anaesthesia. 1996:76:412-414.

Tobias MD, Pilla MA, Rogers C. "Effects of Sequential Hemodilution upon [TEG®] Assessed Coagulation." Anesthesia & Analgesia. Feb. 1995:V80, No. 2S.

Miller BE, Tosone SR, Tam VKH, Kanter KR, Guzzetta NA, Bailey JM, Levy JH. "Hematologic and Economic Impact of Aprotinin in Reoperative Pediatric Cardiac Operations." Ann Thorac Surg 1998;6;535-41.

Robbins P, Forrest M, Von Kier S, Royston D. "[Thrombelastograph®] evaluation of the interaction between ReoPro (C7E3 FAB) and Hemostatic Drugs." Anesthesiology. Sept. 1997. V87, No3A.

Chalkiadis GA, Gibbs NM. "The Effect of Aprotinin on [Thrombelastograph® Analysis] in vitro." Anaesth Instens Care. 1996;24:552-554.

De Hert SG, Farooqi NU, Delrue GL, Broecke PWT, Vermeyen KM, Adriaensen HF. "Dose dependent effect of aprotinin on rate of clot formation." European Journal of Anesthesiology. 1996,13,463-467.

Tuman KJ, McCarthy RJ, Patel RB, Ivankovich AD, "Quantification of Aprotinin Reversal of Severe Fibrinolysis in Dogs Using [Thrombelastograph® Analysis]". Anesth Analog. 1993:76:S1-S476.

Royston D. "High-Dose Aprotinin Therapy: A Review of the First Five Years Experience." Journal of Cardiothoracic and Vascular Anesthesia. February 1992:V6, No 1, pp76-100.

Royston D. "Aprotinin Prevents Bleeding and Has Effects on Platelets and Fibrinolysis." Journal of Cardiothoracic and Vascular Anesthesia. December 1991: V5, No. 6, Suppl 1, pp 18-23.

Mallett S, Rolles K, Cox D, Burroughs A, Hunt B. "Intraoperative Use of Aprotinin (Trasylol) in Orthotopic Liver Transplantation." Transplantation Proceedings. (June), 1991:V23, No.3:pp 1931-1932.

Kang Y, De Wolf AM, Aggarwal S, Campbell E, Martin LK. "In Vitro Study of the Effects of Aprotinin on Coagulation During Orthotopic Liver Transplantation." Transplantation Proceedings. (June), 1991:V23, No.3. pp 1934-35.

Camenzind V, Burkhardt S, Zollinger A, Popovic D, Jamnicki M, Pasch T, Spahn DR. "Citrate Storage Alters Blood Coagulation Parameters as Assessed By [Thrombelastograph® Analysis]." Anesthesiology. Sept. 1998, V89, No 3A, A915.

Weavind LM, Nates JL, Pivalizza E, Doursout MF, Chelly JE. "Thrombelastogram in Coagulation Abnormalities after Gas Embolism." Anesthesiology. Sept. 1998, V89, No 3A, A963.

Acimovic S, Stark J, Exner R, Kurz M, Bacher A, Spiss CK, Zimpfer M. "Effect of Platelet Count on [Thrombelastograph®] Maximum Amplitude: An in Vitro Trial." Anesthesiology. Sept. 1998, V89, No 3A, A964.

Mortier E, Struys M, Rolly G. "Effect of Hemodilution on Coagulation" Presented at the 16th Annual Symposium - Clinical Update in Anesthesiology. San Juan, P.R. January 17-24, 1998.

Tameshwar Ammar. "Factors that influence early extubation". Presented at the 16th Annual Symposium; Clinical Update in Anesthesiology. San Juan, P.R. January 17-24, 1998.

Delaporte-Cerceau S, Samama CM, Riou B, et al. "Ketorolac and Enoxaparin Affect Arterial Thrombosis and Bleeding in the Rabbit." Anesthesiology. May 1998, V88, No. 5.

Kohro S, Yamakage M, Arakawa J, Kotaki M, Omote T, Namiki A. "Surgical/tourniquet pain accelerates blood coagulability but not fibrinolysis." British Journal of Anaesthesia. 1998;80:460-463.

Mardel SN, Saunders FM, Allen H, Menezes G, Edwards CM, Ollerenshaw L, Baddeley D, et al. "Reduced quality of clot formation with gelantin-based plasma substitutes." British Journal of Anaesthesia. 1998;80:204-207.

Kohro S. "The Effects of Propofol on Blood Coagulability and Fibrinolysis by the Use of Thromboelastogram Technique." Anesthesiology. Sept. 1997:V87, No 3A.

Tobias MD, Henry C, Augostides Y. "Lidocaine and bupivicaine exert differential effects upon whole blood coagulation." Anesthesiology. Sept. 1997:V87, No 3A.

McCarthy RJ, Tuman KJ, Ivankovich AD. "Effect of Heparin Reversal Using Platelet Factor 4 on Whole Blood [Thrombelastograph®] (TEG[®]) Measures of Coagulation." Anesthesiology. Sept. 1997: V87, No3A.

Spiess BD. "Coagulation Management Based Upon Whole Blood Coagulation Testing after CPB: [Thrombelastograph® Analysis] and Sonoclot." Presented at the Proactive Hemostasis Management: The Emerging Role of Platelets Symposium. Jan 23-24, 1997. Aspen, CO.

Pivalizza EG, Pivalizza PJ, Weavind LM. "Perioperative [Thrombelastograph® analysis] and sonoclot analysis in morbidly obese patients." Can J Anaesth. 1997;44:9 pp 942-945.

Pivalizza EG, Abramson DC, Harvey A. "Perioperative Hypercoagulability in Uremic Patients: A Viscoelastic Study" Journal of Clinical Anesthesia. 1997:442-445.

Spiess BD, Wall MH, Gillies BS, Fitch JC, Soltow LO, Chandler WL. "A Comparison of [Thrombelastograph® Analysis] with Heparinase or Protamine Sulfate Added In Vitro during Heparinized Cardiopulmonary Bypass." Thromb Haemost. 1997;78:820-6.

Dambisya YM, Lee TL. "A [Thrombelastograph® analysis] study on the in vitro effects of L-arginine and L-NG-nitro arginine methyl ester on human whole blood coagulation and fibrinolysis." Blood Coagul Fibrinolysis. October 1996;7;678-83.

Kornbrust E, Neslund G. "[Thrombelastograph® Analysis] As a Sensitive Tool for Reflecting Imbalances In Whole Blood Coagulation IN VITRO." Presented at the Experimental Biology FASEB meeting in Washington, DC. 1996.

Pivalizza EG, Weavind LM, Pivalizza PJ, King F. "[Thrombelastograph® Analysis] in Morbidly Obese Patients." Anesthesiology. September 1996:V85. No. 3A.

Langenecker-Kozek SA, Kettner S, Lehnhardt R, Schafer B, Zimpfer M. "[Thrombelastograph® Analysis] During Continous Venovenous Hemofiltration and Anticoagulation with Heparin and Prostaglandin E1." Anesthesiology. September 1996:V85. No. 3A.

Khurana S. "[Thrombelastograph® Analysis] can Rapidly Bioassay Fibrinogen." Anesthesiology. September 1996:V85. No. 3A.

Pivalizza EG, Henderson KL, Craig AL. "Discrepancy between [Thrombelastograph® Analysis] and Prothrombin Time." Anesthesiology. May 1996:V84, No. 5.

Stammers AH, Fristoe L, Christensen K, Deptula J, Sydzyik T, Zavadil D, Willett L. "Coagulopathic Induced Membrane Dysfunction During Extracorporeal Membrane Oxygenation A Case Report." American Academy of Cardiovascular Perfusion. January 1996:V17, pp. 119-122.

Tobias MD, Pilla MA, Rogers C, Jobes DR. "Lidocaine Inhibits Blood Coagulation: Implications for Epidural Blood Patch." Anesth Analg. 1996:V82:766-9.

Whitten CW, Allison PM, Latson TW, Ivy R, et al. "Evaluation of Laboratory Coagulation and Lytic Parameters Resulting from Autogolous Whole Blood Tranfusion During Primary Aortocoronary Artery Bypass Grafting." Journal of Clinical Anesthesia. 1996:8:229-235.

Woo S, Sung KS, Kim MC, Cho KH. "Analysis of Residual Heparin Effects after Protamine Reversal by Thromboelastograph and Thrombin Time." Anesth Analg. 1996;82;SCA103.

McCarthy RJ, Pharm D, Stancic Z, et al. "Use of Recombinant Human Tissue Factor (RTF) Thromboplastin As an Adjunct to Whole Blood Thromboelastograph (TEG[®]) Coagulation Monitoring." Anesth Analg. 1996;82;S306.

Nakatsuka M, Weiss JR, et al. "The Effect of Tourniquet Application on Coagulation During Lower Extremity Orthopedic Surgery as Measured by [Thrombelastograph® Analysis]." Anesth Analg. 1996;82;S334.

Swica H, Vinekar C, Belani K, Saez R. "Effect of Lyophilized Cryoprecipitate, Fresh Frozen Plasma, and Platelets on Human Blood - [Thrombelastograph®] Assessment." Anesth Analg. 1996;82;S440.

Pivalizza EG. "DDAVP, [Thrombelastograph® Analysis], and Uremia." Anesth Analg. 1996; 83;1129-35.

SE Patchett, DP O'Donoghue. "Pharmacological manipulation of gastric juice: [Thrombelastograph®] assessment and implications for treatment of gastrointestinal haemorrhage." Gut. 1995;36:358-362.

Schwartz SI, Hinder R, Selby R, Shoemaker W. "Symposium: Bleeding and Transfusions in Surgery." Contemporary Surgery. September 1995 - V 47, No. 3.

Stammers AH, Willett L, et al. "Coagulation Monitoring During Extracorporeal Membrane Oxygenation: The Role of Thrombelastography." Journal of Extra-Corporeal Technology. September 1995, V 27, No. 3.

Vertrees RA, Conti VR, Lick SD, Zwischenberger JB, McDaniel LB, Shulman G. "Adverse Effects of Postoperative Infusion of Shed Mediastinal Blood." Ann Thorac Surg. 1996;62:717-23.

Gibbs NM, Sear JW. "Effect of Ketorolac, Bupivacaine and Low-dose Heparin on [Thrombelastograph®] Variables in Vitro." British Journal of Anaesthesia. July 1995, V75, pp 27-30.

Tobias MD, Pilla MA. "Lidocaine Inhibits CTEG Measured Coagulation: Implications for Epidural Autologous Blood Patch." Anesthesia & Analgesia. Feb. 1995, V80, No. 2S.

James MF, Neil G. "Effect of Magnesium on Coagulation as Measured by [Thrombelastograph® Analysis]." British Journal of Anaesthesia. Jan 1995;V74;92-94.

Chandler WL. "The [Thrombelastograph® Analyzer] and the [Thrombelastograph® Analyzer] Technique." Seminars in Thrombosis and Hemostasis. 1995: Supp 4, V21.

Traverso CI, Caprini JA, Arcelus JI. "The Normal Thromboelastogram and Its Interpretation." Seminars in Thrombosis and Hemostasis. 1995: Supp 4, V21.

Traverso CI, Caprini JA, Arcelus JI. "Application of [Thrombelastograph® Analysis] in Other Medical and Surgical States." Seminars in Thrombosis and Hemostasis. 1995: Supp 4, V21.

Traverso CI, Caprini JA, Arcelus JI, Arcelus IM. "[Thrombelastograph®] Modifications Induced by Intravenous and Subcutaneous Heparin Administration." Seminars in Thrombosis and Hemostasis. 1995:Supp 4, V21.

Traverso CI, Caprini JA, Arcelus JI. "Role of [Thrombelastograph® Analysis] in Evlauating Other Anticoagulant Agents: Warfarin and Heparin-Dihydroergotamine." Seminars in Thrombosis and Hemostasis. 1995:Supp 4, V21.

Iqbal O, Jeske W, Hoppensteadt D, Walenga JM, Fareed J. "The Approach of [Thrombelastograph® Analysis] in the Monitoring of New Synthetic Antithrombotic Agents, GL-522 and GL-2021." Seminars in Thrombosis and Hemostasis. 1995:Supp 4, V21.

Callas D, Iqbal O, Farred J. "Comparison of the Anticoagulant Activities of Thrombin Inhibitors as Assessed by [Thrombelastograph®] Analysis." Seminars in Thrombosis and Hemostasis. 1995:Supp 4, V21.

Iqbal O, Jeske W, Hoppensteadt D, et al. "Procoagulant and Anticoagulant Effects of Intravascular Contrast Media as Assessed by [Thrombelastograph® Analysis]." Seminars in Thrombosis and Hemostasis. 1995:Supp 4, V21.

Caprini JA, Traverso CI, Arcelus JI. "Perspectives on [Thrombelastograph® Analysis] ." Seminars in Thrombosis and Hemostasis. 1995:Supp 4, V21.

Dambisya YM, Lee T-L, Gopalakrishnakone P. "Anticoagulant Effects of Pseudechis Australis (Australian King Brown Snake) Venom on Human Blood: A Computerized Thrombelastography Study." Toxicon. 1995:V33, No. 10, 1378-1382.

Gibbs NM, Sear JW. "Effect of ketorolac, bupivacaine and low-dose heparin on [Thrombelastograph®] variables in vitro." British Journal of Anaesthesia. 1995;75: 27-30.

Arai LD, McNulty SE, Maguire DP. "An Alternate Method for Calibrating the [Thrombelastograph® Analyzer]." Anesthesiology. September 1994:81(3A).

Dambisya YM, Lee T-L, Gopalakrishnakone P. "Action of Calloselasma Rhodostoma (Malayan Pit Viper) Venom on Human Blood Coagulation and Fibrinolysis Using Computerized [Thrombelastograph® Analysis] (CTEG)." Toxicon. 1994:V32, No. 12, 1619-1626.

Kikura M, Levy JH, Safon RA, Meyer KP. "Does Milrinone Produce Platelet Dysfunction in the Cardiac Surgical Patient?" Anesthesiology. Sept. 1993:V79, No.3A.

Turnage SW, Mangar D, Janicki J. "The Effect of Aspirin on the Bleeding Time vs. The Native and Activated Thromboelastogram." Anesthesiology. Sept. 1993:V79, No. 3A.

Dietrich W, Mendler N, Jochum M, Richter JA. "Recombinant Aprotinin (ARG 15 Aprotinin Reduces Hemostatic Activation in Simulated Extracorporeal Circulation." Anesthesiology. Sept. 1993,V79, No. 3A.

Mallett SV, Cox JA. "[Thrombelastograph® Analysis]". British Journal of Anaesthesia. 1992,69:307-313.

Bigeleisen PE, Kang Y. "[Thrombelastograph® analysis] as an aid to regional anesthesia: preliminary communication." Reg Anesth. Jan-Feb.1991 V16;59-61.

Walenga JM, Hoppensteadt D, Koza M, Wallock M, Pifarre R, Fareed J. "Laboratory assays for the evaluation of recombinant hirudin." Haemostasis. 1991:21 Supplement 1:49-63.

Shinoda T, Arakura H, Katakura M, Shirota T, Nakagawa S. "Usefulness of [Thrombelastograph® analysis] for dosage monitoring of low molecular weight heparin and unfractionated heparin during hemodialysis." Artif Organs. Dec. 1990;14;413-15.

Mei Wang, Feng-Yuan Zhuang, Tian Tian. "Analysis of Thromboelastogram On Coagulation and Fibrinolysis." Biorheology. 1988: V25. pp. 539-544.

Hara H, Tamao Y, Kikumoto R, Okamoto S. "Effect of a Synthetic Thrombin Inhibitor MCI-9038 on Experimental Models of Disseminated Intravascular Coagulation In Rabbits." Thrombosis and Haemostasis. (1987):V57 (2) 165-170.

Holloway DA, Zuckerman L, Vagher JP, Mockros LF. "The Effects of Prostacyclin on the Coagulation of Whole Blood." Thromb Haemostasis. 1983:V50 (3) 671-675.

Fran R and Coetzee WJ. "The [Thrombelastograph®] Diagnosis of Hemostatic Defects." Surgical Annuls. 1981:13:75-107.

Lee BY, Trainer FS, Thoden WR and Kavner D. "Monitoring Coagulation Dynamics: [Thrombelastograph® Analysis]." Handbook of Noninvasive Diagnostic Techniques in Vascular Surgery. Appleton-Century-Crofts, 1981:Chapter 7.

Zuckerman L, Cohen E, Vagher JP, et al. "Comparison of [Thrombelastograph® Analysis] with Common Coagulation Tests." Thrombosis and Haemostasis. 1981:46(4): 752-756.

Zuckerman L, Caprini JA, Lipp V, Vagher JP. "Disseminated Intravascular Multiple Systems Activation (DIMSA) following Thermal Injury." Journal of Trauma. June 1978: V18, No. 6, 432-439.

Caprini JA, Lipp V, Zuckerman L, Winchester DP. "Hematologic Changes Following Burns." Journal of Surgical Research. (1977):V22, 626-635.

Ettinger MG. "[Thrombelastograph®] Studies in Cerebral Infarction." Stroke. May-June 1974, V 5, pp. 350-354.

Tyler HM. "Fibrin Crosslinking Demonstrated by [Thrombelastograph® Analysis]." Thrombosis at diatnesis Haomommagica. (1969):V22:398-400.

Sharma SK, Philip J, Wiley J. "Assessment of Plasma Fibrinogen and Platelet Function with [Thrombelastograph® Analysis] Using C7E3 FAB." Anesthesiology. Sept. 1998, V89, No 3A, A1047.

Gonano C, Kettner SC, Panzer OP, Kozek SA, Seibt FA, Stoiser B, Blaicher A, Zimpfer M. "Accuracy of Native and Activated [Thrombelastograph® Analysis] for Assessment of Plasma Fibrinogen Levels." Anesthesiology. Sept. 1998, V89, No 3A, A912.

Paulissian R, Joseph NJ, El-Dibany, Morris EJ, et al. "Can [Thrombelastograph® Analysis] Estimate Plasma Fibrinogen Level." Anesthesiology. Sept. 1997:V87, No 3A.

Goh YK, Tsoi WC, Feng CS, Wickham N, Poon WS. "Haemostatic changes during surgery for primary brain tumors." Journal Neurol Neurosurg Psychiatry. 1997;63:334-338.

Caprini JA, Traverso CI, Walenga JM, Arcelus JI, Fareed J, Spiess BD. "[Thrombelastograph® Analysis]." Seminars in Thrombosis and Hemostasis. (1995): V21, No. 4.

Raina S, Spillert C, Greenstein SM, Lazaro EJ. "Effect of Surgery on Tumor-Induced Accelerated Coagulation in a Rat Carcinoma." Journal of Surgical Research. (1985):V38, 138-142.

Haid M, Winston-Salem NC. "[Thrombelastograph®] Distinction of Malignant From Benign Breast Masses: A Preliminary Report." Southern Medical Journal. V70, No. July 1977:7:774-776.

Caprini JA, Zuckerman L, Cohen E. Vagher JP, Lipp V. "The Identification of Accelerated Coagulability." Thrombosis Research. 1976:9:167-180.

Hathaway WE, Hays T. "Hypercoagulability in Childhood Cancer." Journal of Pediatric Surgery. December 1975:V10, No. 6, 893-899.

McKenzie-Brown AM, Pelle A, Mochizuki T, Vroon D. "Coagulation Changes in Trauma Patients." Anesth Analg. 1998;86;S88.

Kaufmann CR, Dwyer KM, Crews JD, Dols SJ, Trask AL. "Usefulness of [Thrombelastograph® Analysis] in Assessment of Trauma Patient Coagulation." Journal of Trauma, Injury, Infection, and Critical Care. 1997:V42, No4.

Davis CL, Chandler WL. "[Thrombelastograph® analysis] for the prediction of bleeding after transplant renal biopsy." J AM Soc Nephrol. Oct 1995;V6;1250-55.

Pivalizza E et al. "[Thrombelastograph® Analysis] in Patients With Chronic Renal Failure." Anesthesiology. 1995; V83, 3A, A90.

Holloway SD, Vagher PJ, Caprini JA, et al. "[Thrombelastograph® Analysis] of Blood from Subjects with Chronic Renal Failure." Thrombosis Research. 1987:45;817 825.

Suchecki T. "The so-called Onion-Like Shape Thromboelastogram in Dialyzed Uraemic Patients." Thrombos. Diathes. Haemorrh. (Stuttg.) 1974:31:513.

Szefner J, Cabrol C. "Control and Treatment of Hemostasis in Patients with a Total Artificial Heart: The Experience of La Pitié." Anticoagulation, Hemostasis, and Blood Preservation in Cardiovascular Surgery. 1993; Chapter 17.

Copeland JG, Tsau PH, Arabia FA, Xie T. "Correlation of Clinical Embolic Events with Coagulability in a Patient with a Total Artificial Heart." Journal of Heart and Lung Transplantation. 1995; V14, No. 5.

Wenker OC, Wojciechowski Z, Sheinbaum R, Zisman E. "[Thrombelastograph® Analysis]." The Internet Journal of Anesthesiology. 1997;Vol1N3:http://www.ispub.com/journals/ IJA/Vol1N3/teg.htm. Published July 1, 1997; Updated August 4, 1997.

Petroianu GA, Werth WA, Maleck WH, Schummer B, Rüfer. "[Thrombelastograph® analysis] in male, pregnant and fetal minipigs." Scand. J. Lab. Animal Science. 1998, Supplement 1, V 25.

Feirer N, Hönemann, Durieux M. "Prolonged Bupivacaine Exposure Inhibits Blood Coagulation." Anesthesiology. Sept. 1998;V89;No 3A, A836.